Data / Federal awards / NAICS 541714 / AMGEN USA INC
AMGEN USA INC: 8 federal contract awards, $345.8 million obligated (FY2024 to FY2027)
AMGEN USA INC (UEI XPGNQMXHP493), Thousand Oaks, CA, received 8 federal prime contract awards with $345.8 million obligated in fiscal years 2024 to 2027, from 2 agencies under 3 NAICS codes. Its largest buyer is Department of Health and Human Services ($345.8 million) and its largest code is NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology).
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- UEI
- XPGNQMXHP493
- Location
- Thousand Oaks, CA
- Business size
- Other Than Small Business
- Contract awards
- 8
- Obligated
- $345.8 million
- First action in window
- 2023-10-01
- Latest action
- 2026-09-28
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 2 | $345.8 million |
| 325412 | Pharmaceutical Preparation Manufacturing | 5 | $65,210 |
| 325414 | Biological Product (except Diagnostic) Manufacturing | 1 | $0 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 3 | $345.8 million |
| Department of Veterans Affairs | 5 | $65,210 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $130 million |
| FY2025 | $89.9 million |
| FY2026 | $126 million |
Contract awards
All 8 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75A50122C00065 | Department of Health and Human Services | Definitive Contract | 541714 | TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN. | $344,956,700 | $839,875,190 | September 30, 2022 | September 29, 2032 | Newbury Park, CA | usaspending.gov |
| 75A50124C00011 | Department of Health and Human Services | Definitive Contract | 541714 | VENDOR MANAGED INVENTORY (VMI) SERVICES FOR USG PROCURED 165,906 DOSES OF NEULASTA PRODUCT TO MITIGATE INJURIES CAUSED BY EXPOSURE TO CHEMIC | $811,924 | $811,924 | March 12, 2024 | December 16, 2024 | Newbury Park, CA | usaspending.gov |
| 36C26024F0036 | Department of Veterans Affairs | Delivery Order | 325412 | TAVNEOS (AVACOPAN) | $65,210 | $65,478 | October 1, 2023 | September 30, 2024 | La Vergne, TN | usaspending.gov |
| 36E79720D0006 | Department of Veterans Affairs | IDC | 325412 | ERENUMAB-AOOE 70MG/ML AUTOINJECTOR 1ML ERENUMAB-AOOE 140MG/ML AUTOINJECTOR 1ML | $0 | $58,968,306 | February 26, 2020 | usaspending.gov | ||
| 36E79725D0053 | Department of Veterans Affairs | IDC | 325412 | NEW AWARD FOR TRASTUZUMAB WITH AMGEN. ORDERING PERIOD IS NOV 15, 2025 THROUGH NOV 14, 2026 WITH FOUR ONE-YEAR OPTIONS. | $0 | $15,375,050 | November 15, 2025 | usaspending.gov | ||
| 36E79725D0009 | Department of Veterans Affairs | IDC | 325412 | 2 LINE ITEMS CALCITONIN GENE-RELATED PEPTIDES (CGRP) AWARDED FOR A BASE YEAR PERIOD OF 2/26/2025 TO 2/25/2026 PLUS FOUR ONE-YEAR OPTION PERI | $0 | $100,527,334 | February 26, 2025 | usaspending.gov | ||
| 36F79721D0086 | Department of Veterans Affairs | FSS | 325412 | 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | $0 | $3,372,000,000 | February 1, 2021 | usaspending.gov | ||
| 75A50118F33003 | Department of Health and Human Services | Delivery Order | 325414 | RTOR NUMBER: RTOR-CSF-0004 MAINTENANCE OF PREVIOUSLY PURCHASED COLONY STIMULATING FACTOR(S) (G- OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARI | $0 | $657,406 | September 19, 2018 | March 16, 2024 | Newbury Park, CA | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- All recipients under NAICS 325412 Pharmaceutical Preparation Manufacturing
- All recipients under NAICS 325414 Biological Product (except Diagnostic) Manufacturing
- Open opportunities under NAICS 541714
- Open opportunities under NAICS 325412
- Open opportunities under NAICS 325414
Updated October 6, 2026. Read from USAspending.gov. Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.